M. Lans
Impact in
-
- Carcinogens and Genotoxicity Assessment
- Cancer Genomics and Diagnostics
- Nutrition and Dietetics top 10%
- Vitamin C and Antioxidants Research
- Vitamin K Research Studies
Papers in
- Oncology 8
- Drug Transport and Resistance Mechanisms 4
- Co-authors
- Marcel Roberfroid (16 shared papers)Henryk Taper (10 shared papers)H Taper (11 shared papers)Véronique Préat (9 shared papers)Marcel Roberfroid (8 shared papers)J. L. Michaux (1 shared paper)Magda Opsomer (2 shared papers)R.M.E. Vos (1 shared paper)
In The Last Decade
M. Lans
29 papers receiving 422 citations
Peers
Comparison fields: 5 of 63
- Cancer Research 107
- Nutrition and Dietetics 92
- Toxicology 16
- Pharmacology 36
- Biochemistry 26
Countries citing papers authored by M. Lans
This map shows the geographic impact of M. Lans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Lans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Lans more than expected).
Fields of papers citing papers by M. Lans
This network shows the impact of papers produced by M. Lans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Lans. The network helps show where M. Lans may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Lans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1987 | 89 | |
| 2 | 1983 | 49 | |
| 3 | 1986 | 32 | |
| 4 | 1988 | 31 | |
| 5 | 1989 | 23 | |
| 6 | 1989 | 23 | |
| 7 | 1989 | 16 | |
| 8 | Comparison of the biological effects of phenobarbital and nafenopin on rat hepatocarcinogenesis. | 1986 | 16 |
| 9 | 1988 | 15 | |
| 10 | Variations in serum alkaline DNase activity: a possible clinical test for therapeutic prognosis of human tumors. | 1987 | 15 |
| 11 | Serum alkaline deoxyribonuclease activity, a sensitive marker for the therapeutic monitoring of cancer patients: methodological aspects. | 1993 | 14 |
| 12 | 1988 | 13 | |
| 13 | 1984 | 13 | |
| 14 | 1990 | 12 | |
| 15 | 1989 | 12 | |
| 16 | 1984 | 11 | |
| 17 | 1987 | 10 | |
| 18 | 1986 | 8 | |
| 19 | 1983 | 7 | |
| 20 | 1980 | 6 |
About M. Lans
M. Lans is a scholar working on Oncology, Molecular Biology, Cancer Research, Epidemiology and Pharmacology, having authored 30 papers that have together received 437 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (4 papers), Drug Transport and Resistance Mechanisms (4 papers), Acute Lymphoblastic Leukemia research (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Alkaline Phosphatase Research Studies (3 papers), Computational Drug Discovery Methods (2 papers), Sulfur Compounds in Biology (2 papers) and Ovarian cancer diagnosis and treatment (2 papers). The work is most often cited by research in Cancer Research (107 citations), Nutrition and Dietetics (92 citations), Toxicology (16 citations), Pharmacology (36 citations) and Biochemistry (26 citations). M. Lans has collaborated with scholars based in Belgium and Sweden. Frequent co-authors include Marcel Roberfroid, Henryk Taper, H Taper, Véronique Préat, Marcel Roberfroid, J. L. Michaux, Magda Opsomer, R.M.E. Vos, J.H.M. Temmink and Peter J. van Bladeren. Their work appears in journals such as Carcinogenesis, International Journal of Cancer, Blood, Cancer and Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.